Skip to main content

Table 1 Main characteristics according to tertiles of fibroblast growth factor 21

From: Fibroblast growth factor 21 is associated with widening QRS complex and prolonged corrected QT interval in patients with stable angina

Parameter

Low FGF21

 ≤ 28.5 pg/mL

Medium FGF21

 = 28.6–65.8 pg/mL

High FGF21

 > 65.8 pg/mL

P-value

Number

108

106

107

 

Sex (male/female)

82/26

84/22

75/32

0.294

Age (years)

66.5 ± 12.0

68.0 ± 11.8

72.5 ± 11.6

0.001

Hypertension (n, %)

76(70.4)

78(73.6)

80(74.8)

0.754

Hyperlipidemia (n, %)

71(65.7)

75(70.8)

56(52.3)

0.016

Diabetes mellitus (n, %)

37(34.3)

50(47.2)

51(47.7)

0.079

Left ventricular hypertrophy (n, %)

50(46.3)

52(49.1)

72(67.3)

0.032

MACEs (n, %)

45(41.7)

59(55.7)

49(45.8)

0.109

All-cause Mortality (n, %)

8(7.4)

14(13.2)

21(19.6)

0.031

Current smoker (n, %)

46(42.6)

50(47.2)

33(30.8)

0.043

Body mass index (kg/m2)

25.7 ± 3.9

26.1 ± 3.6

24.7 ± 4.5

0.044

Waist-to-hip ratio

0.93 ± 0.07

0.94 ± 0.06

0.97 ± 0.12

0.010

Systolic BP (mmHg)

130 ± 22

131 ± 22

130 ± 26

0.926

Diastolic BP (mmHg)

76 ± 14

77 ± 12

77 ± 15

0.992

LVEF (%)

60.8 ± 15.1

58.8 ± 15.5

55.5 ± 16.0

0.045

Electrocardiography parameters

 Heart rate (bpm)

74.0 ± 17.6

77.6 ± 20.0

83.1 ± 20.8

0.003

 PR interval (ms)

167.5 ± 30.4

169.4 ± 26.5

172.7 ± 39.7

0.540

 QRS duration (ms)

93.7 ± 15.8

98.4 ± 22.1

103.1 ± 22.2

0.004

 QT interval (ms)

394.7 ± 46.0

399.3 ± 44.9

401.1 ± 57.9

0.626

 QTc interval (ms)

434.2 ± 35.6

444.5 ± 35.6

461.9 ± 45.3

 < 0.0001

Wide QRS complex† (n, %)

8(7.4)

12(11.3)

33(30.8)

 < 0.0001

Prolonged QTc interval‡ (n, %)

30(27.8)

32(30.2)

51(47.7)

0.004

Medication (n, %)

 Anti-arrhythmic medication

10(9.3)

8(7.6)

10(9.4)

0.871

 Beta-blockers

58(53.7)

57(53.8)

49(45.8)

0.406

 Diuretics

31(28.7)

33(31.1)

31(29.0)

0.913

 Statins

66(61.1)

59(55.7)

45(42.1)

0.016

Number of diseased vessels (%)

 Single-vessel disease

35(32.4)

33(31.1)

28(26.2)

0.574

 Two-vessel disease

24(22.2)

36(34.0)

39(36.5)

0.054

 Three-vessel disease

49(45.4)

37(34.9)

40(37.4)

0.260

  1. Data are expressed as the mean ± SD, number (percentage), or median (interquartile range). FGF fibroblast growth factor; QTc corrected QT; LVEF left ventricular ejection fraction; MACEs major adverse cardiovascular events
  2. †Wide QRS complex was defined as a QRS duration > 120 ms
  3. ‡Prolonged QTc was defined as a men ≥ 451 ms or women ≥ 471 ms